Th1 and Th2 epitopes of Cowdria polymorphic gene 1 of Ehrlichia ruminantium.
ELISA
ELISpot
Heartwater
PBMC
cytokine qRT-PCR
flow cytometry
lymphocyte proliferation assay
vaccine epitopes
Journal
The Onderstepoort journal of veterinary research
ISSN: 2219-0635
Titre abrégé: Onderstepoort J Vet Res
Pays: South Africa
ID NLM: 0401107
Informations de publication
Date de publication:
23 Mar 2023
23 Mar 2023
Historique:
received:
02
08
2022
accepted:
17
11
2022
revised:
03
11
2022
medline:
13
4
2023
entrez:
12
4
2023
pubmed:
13
4
2023
Statut:
epublish
Résumé
Cowdria polymorphic gene 1 (cpg1, Erum2510, ERUM_RS01380) has been shown to induce 30% and 100% protection in sheep immunised by deoxyribonucleic acid (DNA) prime combined with DNA boost and DNA prime combined with protein boost, respectively, against heartwater infection via needle challenge. To localise its antigenic regions for inclusion in a multi-epitope DNA vaccine against heartwater, Erum2510 was cleaved into five overlapping subfragments. These subfragments were expressed individually in an Escherichia coli host expression system and evaluated for their ability to induce proliferative responses, Th1 and Th2 cytokines (interferon gamma [IFN-γ] and interleukin 4 [IL-4]) via enzyme-linked immunospot (ELISpot), quantitative real time polymerase chain reaction (qRT-PCR) and flow cytometry. Recombinant (r)proteins 3 and 4 were shown to induce immunodominant Th1 and Th2 immune responses characterised by the secretion of effector cytokines IFN-γ and IL-4 in addition to differential messenger ribonucleic acid (mRNA) expression of tumour necrosis factor (TNF), IL-2, IL-1, IL-18, IL-10, transforming growth factor (TGF), granulocyte-macrophage colony-stimulating factor (GM-CSF) and inducible nitric oxide synthase (iNOS). Thirty-seven overlapping synthetic peptides (16 mer) spanning the lengths of these immunodominant rproteins were synthesised and assayed. A peptide pool comprising p9 and p10 derived from rprotein 3 induced a Th1-biased immune response. A peptide pool comprising p28 and p29 derived from rprotein 4 induced a mixed Th1 and Th2 immune response characterised by secretion of IFN-γ and differential mRNA expression of IL-1, IL-2, IL-10, IL-12, iNOS, TGF, TNF and GM-CSF. Only one of the peptides (p29) induced secretion of IL-4. Phenotypic analysis showed significant activation of cluster of differentiation 8+ (CD8+), cluster of differentiation 4+ (CD4+) and B+ lymphocyte populations. Findings suggest that Erum2510 rproteins and synthetic peptides can induce both cellular and humoral immune responses, thereby implicating their importance in protection against heartwater.Contribution: This study will facilitate the design of an effective multi-epitope DNA vaccine against heartwater that will contribute to control this economically important disease in sub-Saharan Africa and beyond.
Identifiants
pubmed: 37042556
doi: 10.4102/ojvr.v90i1.2070
pmc: PMC10091069
doi:
Substances chimiques
Cytokines
0
Epitopes
0
Vaccines, DNA
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1-e15Références
Virol J. 2011 May 16;8:232
pubmed: 21575169
Onderstepoort J Vet Res. 1970 Sep;37(3):147-9
pubmed: 4115284
Vaccine. 2002 Jan 15;20(7-8):1215-25
pubmed: 11803084
J Immunol. 2005 Mar 15;174(6):3306-16
pubmed: 15749862
Onderstepoort J Vet Res. 2001 Mar;68(1):37-40
pubmed: 11403428
FEMS Microbiol Lett. 1997 Sep 1;154(1):73-9
pubmed: 9297823
Vaccine. 2008 Aug 12;26(34):4363-71
pubmed: 18602727
Res Vet Sci. 1995 Jan;58(1):46-9
pubmed: 7709059
Vet Microbiol. 2002 Mar 22;85(3):259-73
pubmed: 11852193
Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):978-81
pubmed: 20332253
Clin Cancer Res. 2004 Aug 1;10(15):5004-13
pubmed: 15297401
Parasitol Today. 1999 Jul;15(7):286-90
pubmed: 10377532
Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 2):S81-5
pubmed: 10988157
Vet Immunol Immunopathol. 2004 Mar;98(1-2):49-57
pubmed: 15127841
Vet Immunol Immunopathol. 2019 Jan;207:1-9
pubmed: 30593344
Vaccine. 2000 Jun 15;18(25):2902-14
pubmed: 10812234
J Adv Vet Anim Res. 2019 Mar 24;6(2):174-182
pubmed: 31453188
Vet Microbiol. 2008 Oct 15;131(3-4):258-65
pubmed: 18511221
Infect Immun. 1998 May;66(5):1855-60
pubmed: 9573061
Int Immunol. 1996 May;8(5):745-55
pubmed: 8671663
Am J Vet Res. 1982 Jul;43(7):1279-82
pubmed: 6808870
Exp Parasitol. 2005 Aug;110(4):374-83
pubmed: 15907838
Onderstepoort J Vet Res. 1990 Dec;57(4):215-21
pubmed: 1705686
Vaccine. 2007 Mar 8;25(12):2316-24
pubmed: 17224211
Front Immunol. 2019 Oct 11;10:2420
pubmed: 31681308
Vaccine. 2019 Jul 18;37(31):4354-4363
pubmed: 31248684
Front Immunol. 2018 Jun 07;9:888
pubmed: 29930549
Vet Immunol Immunopathol. 2010 Oct 15;137(3-4):217-25
pubmed: 20566221
Int J Syst Evol Microbiol. 2001 Nov;51(Pt 6):2145-2165
pubmed: 11760958
Vet Immunol Immunopathol. 2012 Jan 15;145(1-2):340-9
pubmed: 22261504
Vet Parasitol. 1994 Aug;54(1-3):223-48
pubmed: 7846852
J Immunol Res. 2015;2015:348401
pubmed: 26380320
J Leukoc Biol. 2007 Jun;81(6):1335-44
pubmed: 17400611
Vaccine. 2007 May 22;25(21):4312-23
pubmed: 17418918
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Mol Immunol. 2019 Mar;107:106-114
pubmed: 30711907
BioDrugs. 2007;21(3):145-56
pubmed: 17516710
Onderstepoort J Vet Res. 2016 Aug 30;83(1):e1-e11
pubmed: 27608502
Dev Biol (Basel). 2003;114:121-36
pubmed: 14677683
Onderstepoort J Vet Res. 2009 Mar;76(1):81-8
pubmed: 19967932
Vaccine. 2010 Apr 30;28(20):3531-9
pubmed: 20338214
Onderstepoort J Vet Res. 1987 Sep;54(3):489-91
pubmed: 3329333